FibroGen, Inc.
FGEN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,324,583 | $2,156,234 | $37,479,591 | $32,553,023 |
| - Cash | $50,482 | $113,688 | $155,700 | $171,223 |
| + Debt | $73,092 | $170,455 | $89,885 | $117,347 |
| Enterprise Value | $1,347,193 | $2,213,001 | $37,413,776 | $32,499,147 |
| Revenue | $29,621 | $46,803 | $140,734 | $235,309 |
| % Growth | -36.7% | -66.7% | -40.2% | – |
| Gross Profit | $14,060 | $42,841 | $120,454 | -$213,883 |
| % Margin | 47.5% | 91.5% | 85.6% | -90.9% |
| EBITDA | -$142,428 | -$305,197 | -$282,825 | -$333,721 |
| % Margin | -480.8% | -652.1% | -201% | -141.8% |
| Net Income | -$47,579 | -$284,232 | -$293,654 | -$290,023 |
| % Margin | -160.6% | -607.3% | -208.7% | -123.3% |
| EPS Diluted | -0.48 | -2.92 | -3.15 | -3.15 |
| % Growth | 83.6% | 7.3% | 0% | – |
| Operating Cash Flow | -$137,999 | -$315,021 | -$145,933 | -$82,232 |
| Capital Expenditures | -$266 | -$2,519 | -$38,741 | -$30,186 |
| Free Cash Flow | -$138,265 | -$317,540 | -$184,674 | -$112,418 |